Insider · CIK 0001791058
Eric Swayze
officer
Files at IONS (IONIS PHARMACEUTICALS INC). First filing Oct 17, 2024, latest Oct 16, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 8
$0 bought, $3.2M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IONS: IONIS PHARMACEUTICALS INC
IONSOct 9, 2026 · close 45.28
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | IONIS PHARMACEUTICALS INC | $3,902 53 shares | -17% | +186% from low0% from high | |
| 32Weak | IONIS PHARMACEUTICALS INC | $473k 6,849 shares | -18% | +171% from low-0% from high | |
| 40Moderate | IONIS PHARMACEUTICALS INC | $1.8M 27,114 shares | -53% | +158% from low0% from high | |
| 34Weak | IONIS PHARMACEUTICALS INC | $553k 11,130 shares | -23% | +125% from low0% from high | |
| 36Weak | IONIS PHARMACEUTICALS INC | $44k 1,367 shares | -3% | - | |
| 33Weak | IONIS PHARMACEUTICALS INC | $236k 7,176 shares | -14% | - | |
| 16Weak | IONIS PHARMACEUTICALS INC | $45k 1,194 shares | -3% | - | |
| 10Weak | IONSsell IONIS PHARMACEUTICALS INC | $2,031 53 shares | -25% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 15, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stockindirect: by Son | +125 | $0.00 | $0 | 309 | Oct 16, 2025 |
| Oct 16, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stockindirect: by Son | -53 | $73.62 | $3,902 | 256 | Oct 16, 2025 |
| Oct 15, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Restricted Stock Unitderivativeindirect: by Son | -125 | $0.00 | $0 | 497 | Oct 16, 2025 |
| Oct 6, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -6,849 | $69.02 | $473k | 30,453 | Oct 8, 2025 |
| Oct 1, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock10b5-1 | +14,142 | $53.77 | $760k | 51,444 | Oct 2, 2025 |
| Oct 1, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -14,142 | $66.09 | $935k | 37,302 | Oct 2, 2025 |
| Oct 2, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock10b5-1 | +12,972 | $53.77 | $698k | 50,274 | Oct 2, 2025 |
| Oct 2, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -12,972 | $66.23 | $859k | 37,302 | Oct 2, 2025 |
| Oct 1, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -14,142 | $0.00 | $0 | 12,972 | Oct 2, 2025 |
| Oct 2, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -12,972 | $0.00 | $0 | 0 | Oct 2, 2025 |
| Sep 2, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -10,000 | $49.22 | $492k | 38,432 | Sep 4, 2025 |
| Sep 2, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -1,130 | $53.68 | $61k | 37,302 | Sep 4, 2025 |
| Feb 28, 2025 | IONS IONIS PHARMACEUTICALS INC | JOther Common Stock | +415 | $28.21 | $12k | 48,432 | Mar 4, 2025 |
| Jan 30, 2025 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Common Stock | +3,714 | $0.00 | $0 | 49,384 | Feb 3, 2025 |
| Jan 31, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock | -1,367 | $32.31 | $44k | 48,017 | Feb 3, 2025 |
| Jan 15, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock | +19,111 | $0.00 | $0 | 52,824 | Jan 17, 2025 |
| Jan 16, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock | -7,154 | $32.84 | $235k | 45,670 | Jan 17, 2025 |
| Jan 15, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stockindirect: by Son | +49 | $0.00 | $0 | 206 | Jan 17, 2025 |
| Jan 16, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stockindirect: by Son | -22 | $32.70 | $719 | 184 | Jan 17, 2025 |
| Jan 15, 2025 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Performance Restricted Stock Unitsderivative | +22,000 | $0.00 | $0 | 64,482 | Jan 17, 2025 |
| Jan 15, 2025 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Restricted Stock Unitderivative | +33,000 | $0.00 | $0 | 79,728 | Jan 17, 2025 |
| Jan 15, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Restricted Stock Unitderivative | -19,111 | $0.00 | $0 | 60,617 | Jan 17, 2025 |
| Jan 15, 2025 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Restricted Stock Unitderivativeindirect: by Son | +245 | $0.00 | $0 | 671 | Jan 17, 2025 |
| Jan 15, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Restricted Stock Unitderivativeindirect: by Son | -49 | $0.00 | $0 | 622 | Jan 17, 2025 |
| Jan 2, 2025 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +22,000 | $0.00 | $0 | 22,000 | Jan 6, 2025 |
| Jan 2, 2025 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Non-Qualified Stock Option (right to buy)derivativeindirect: by Son | +163 | $0.00 | $0 | 163 | Jan 6, 2025 |
| Nov 12, 2024 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -1,194 | $37.92 | $45k | 33,713 | Nov 14, 2024 |
| Oct 15, 2024 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stockindirect: by Son | +125 | $0.00 | $0 | 210 | Oct 17, 2024 |
| Oct 16, 2024 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stockindirect: by Son | -53 | $38.31 | $2,031 | 157 | Oct 17, 2024 |
| Oct 15, 2024 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Restricted Stock Unitderivativeindirect: by Son | -125 | $0.00 | $0 | 426 | Oct 17, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.